Skip to search formSkip to main contentSkip to account menu

Gadovist

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

gadobutrol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Novel CMR techniques enable detection of even mild autoimmune myocarditis in a patient with systemic lupus erythematosus
2010
2010
Evaluation of Gadodiamide Versus Gadobutrol for Contrast-Enhanced MR Imaging in a Rat Brain Glioma Model at 1.5 and 3 T
Purpose:To compare equivalently-dosed (0.1 mmol/kg) gadobutrol (Gadovist) and gadodiamide (Omniscan) in a rat brain glioma model… 
2008
2008
Speciation analysis of gadolinium-based MRI contrast agents in blood plasma by hydrophilic interaction chromatography/electrospray mass spectrometry.
The first analytical method for simultaneous speciation analysis of five of the most important gadolinium-based magnetic… 
2008
2008
Gadovist in Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune inflammatory disease of the nervous system due to a still unknown antigen.1 While the… 
2007
2007
Toxicological assessment of gadolinium release from contrast media.
2004
2004
Encapsulation of gadobutrol in AVE-based liposomal carriers for MR detectability.
2002
2002
Vergleich von MultiHance® und Gadovist® zur zerebralen MR-Perfusionsmessung bei gesunden Probanden
ZusammenfassungZur Evaluierung des gering proteinbindenden MR-Kontrastmittels MultiHance® und des einmolaren MR-Kontrastmittels… 
2002
2002
Peripheral run-off CE-MRA with a 1.0 molar gadolinium chelate (Gadovist) with intraarterial DSA comparison.
Highly Cited
2000
Highly Cited
2000
Cerebral MR perfusion imaging: First clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a double‐blinded randomized dose‐finding study
The purpose of this study was to evaluate efficacy and safety of the 1 M gadolinium chelate Gadovist 1.0 for assessment of… 
1996
1996
Verbessert die Hochdosisgabe eines paramagnetischen Kontrastmittels (Gadovist®) die diagnostische Aussage der Magnetresonanztomographie bei Glioblastomen?
Ziel: Material und Methode: Ergebnisse: Schlußfolgerungen: Purpose: Material and methods: Results: Conclusions: 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)